Hyponatraemia for the clinical endocrinologist

Clinical Endocrinology

Volumn 63, Issue 4, 2005, Pages 366-374

  Reynolds, Rebecca M ^a   Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ARGIPRESSIN; CARBAMAZEPINE; CHLORPROMAZINE; GLUCOSE; HYPOTONIC SOLUTION; OMEPRAZOLE; OXYTOCIN; PHENOTHIAZINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SODIUM; THIAZIDE DIURETIC AGENT; VASOPRESSIN; WATER;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; CLINICAL FEATURE; DIURESIS; FLUID BALANCE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOPITUITARISM; HYPOTHYROIDISM; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MEDICAL PROFESSION; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; SALT LOSING NEPHRITIS; SODIUM BALANCE; WATER LOADING; WATER LOSS;

EID: 26644472166     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02318.x     Document Type: Review

References (57)

1. Miller, M., Morley, J.E. & Rubenstein, L.Z. (1995) Hyponatraemia in a nursing home population. Journal of the American Geriatric Society, 43, 1410-1413.
2. Arieff, A.I. (1986) Hyponatraemia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. New England Journal of Medicine, 314, 1529-1535.
3. Anderson, R.J. (1986) Hospital-acquired hyponatraemia. Kidney International, 29, 1237-1247.
4. Lee, D.S., Austin, P.C., Rouleau, J.L., Liu, P.P., Naimark, D. & Tu, J.V. (2003) Predicting mortality among patients hospitalized for heart failure: derviation and validation of a clinical model. Journal of the American Medical Association, 290, 2581-2587.
5. Arroyo, V., Rodes, J., Gutierrez-Lizarraga, M.A. & Revert, L. (1976) Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. American Journal of Digestive Diseases, 21, 249-256.
6. Kumar, S. & Berl, T. (1998) Sodium. Lancet, 352, 220-228.
7. Baylis, P.H. & Thompson, C.J. (1988) Osmoregulation of vasopressin secretion and thirst in health and disease. Clinical Endocrinology, 29, 549-576.
8. McKenna, K. & Thompson, C.J. (1988) Osmoregulation in clinical disorders of thirst appreciation. Clinical Endocrinology, 49, 139-152.
9. Adrogué, H.J. & Madias, N.E. (2000) Hyponatraemia. New England Journal of Medicine, 342, 1581-1589.
10. Smith, D.M., McKenna, K. & Thompson, C.J. (2000) Hyponatraemia. Clinical Endocrinology, 52, 667-678.
11. Preston, G.M., Carroll, T.P., Guggino, W.B. & Agre, P. (1992) Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science, 256, 385-387.
12. Ishikawa, S. & Schrier, R.W. (2003) Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clinical Endocrinology, 58, 1-17.
13. Seckl, J.R., Williams, T.D. & Lightman, S.L. (1986) Oral hypertonic saline causes transient fall of vasopressin in humans. American Journal of Physiology, 251 (2pt, 2), R214-R217.
14. Almond, C.S.D., Shin, A.Y., Fortescue, E.B., Mannix, R.C., Wypij, D., Binstadt, B.A., Duncan, C.N., Olson, D.P., Salerno, A.E., Newburger, J.A. & Greenes, D.S. (2005) Hyponatraemia among runners in the Boston marathon. New England Journal of Medicine, 352, 1550-1556.
15. Katz, M.A. (1973) Hyperglycemia-induced hyponatremia: calculation of expected serum sodium depression. New England Journal of Medicine, 289, 843-844.
16. Hillier, T.A., Abbott, R.D. & Barrett, E.J. (1999) Hyponatraemia: evaluating the correction factor for hyperglycemia. American Journal of Medicine, 106, 399-403.
17. Saito, T., Ishikawa, S., Abe, K., Kamoi, K., Yamada, K., Shimizu, K., Sarita, T. & Yoshida, S. (1997) Acute aquaresis by the nonpeptide argine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Clinical Endocrinology and Metabolism, 82, 1054-1057.
18. Diederich, S., Franzen, N.-F., Bahr, V. & Oelkers, W. (2003) Severe hyponatraemia due to hypopituitarism with adrenal insuffiency: report on 28 cases. European Journal of Endocrinology, 6, 609-617.
19. Nelson, P.B., Seif, S.M., Maroon, J.C. & Robinson, G.A. (1981) Hyponatraemia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Neurosurgery, 55, 938-941.
20. Wijdick, E.F.M., Veermeulen, M., ten Haaf, J.A., Hijdra, A., Bakker, W.H. & van Gijn, J. (1985) Volume depletion and natriuresis in patients with a ruptured intracranial aneursym. Annals of Neurology, 18, 211-216.
21. Sivakumar, V., Rajshekhar, V. & Chandy, M.J. (1994) Management of neourosurgical patients with hyponatraemia and natriuresis. Neurosurgery, 43, 269-274.
22. Palmer, B.F. (2003) Hyponatraemia in patients with central nervous system disease: SIADH versus CSW. Trends in Endocrinology and Metabolism, 14, 182-187.
23. Singh, S., Bohn, D., Carlotti, A.P.C., Cusimano, M., Rukta, J.T. & Halperin, M.L. (2002) Cerebral salt wasting: truths, fallacies, theories and challenges. Critical Care Medicine, 30, 2575-2579.
24. Montengro, J., Gonzalez, O., Saracho, R., Aguirre, R., Gonzalez, O. & Martinez, I. (1996) Changes in renal function in primary hypothyroidism. American Journal of Kidney Disease, 27, 139-140.
25. Bartter, F.C. & Schwartz, W.B. (1967) The syndrome of inappropriate secretion of antidiuretic hormone. American Journal of Medicine, 42, 790-806.
26. Feldman, B.J., Rosenthal, S.M., Vargas, G.A., Fenwick, R.G., Huang, E.A., Matsuda-Abedini, M., Lustig, R.H., Mathias, R.S., Portale, A.A., Miller, W.L. & Gitelman, S.E. (2005) Nephrogenic syndrome of inappropriate antidiuresis. New England Journal of Medicine, 352, 1884-1890.
27. Ashraf, N., Locksley, R. & Arieff, A.I. (1981) Thiazide-induced hyponatraemia associated with death or neurologic damage in outpatients. American Journal of Medicine, 70, 1163-1168.
28. Ellis, S.J. (1995) Severe hyponatraemia: complications and treatment. Quarterly Journal of Medicine, 88, 905-909.
29. Beck, L.H. (1979) Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. New England Journal of Medicine, 301, 528-530.
30. Decaux, G., Musch, W., Penninckx, R. & Soupart, A. (2003) Low plasma bicarbonate level in hyponatraemia related to adrenocorticotropin deficiency. Journal of Clinical Endocrinology and Metabolism, 88, 5255-5257.
31. Saeed, B.O., Beaumont, D., Handley, G.H. & Weaver, J.H. (2002) Severe hyponatraemia: investigation and management in a district general hospital. Journal of Clinical Pathology, 55, 893-896.
32. Cole, C.D., Gottfried, O.N., Liu, J.K. & Couldwell, W.T. (2004) Hyponatraemia in the neurosurgical patient: diagnosis and management. Neurosurgical Focus, 16, E9.
33. Oeklers, W. (1989) Hyponatraemia and inappropriate secretion of antidiuretic hormone in patients with hypopituitarism. New England Journal of Medicine, 321, 492.
34. Sterns, R.H. (1987) Severe symptomatic hyponatraemia: treatment and outcome: a study of 64 cases. Annals of International Medicine, 107, 656-664.
35. Kamel, K.S. & Bear, R.A. (1993) Treatment of hyponatraemia: a quantitative analysis. American Journal of Kidney Diseases, 21, 439-443.
36. Fried, L.F. & Pavelsky, P.M. (1997) Hyponatraemia and hypernatraemia. The Medical Clinics of North America, 81, 585-609.
37. Laureno, R. & Karp, B.I. (1997) Myelinolysis after correction of hyponatraemia. Annals of International Medicine, 126, 57-62.
38. Sterns, R.H., Cappuccio, J.D., Silver, S.M. & Cohen, E.P. (1994) Neurologic sequelae after treatment of severe hyponatraemia: a multicenter perspective. Journal of the American Society of Nephrology, 4, 1522-1530.
39. Norenberg, M.D., Leslie, K.O. & Robertson, A.S. (1982) Association between rise in serum sodium concentration and central pontine myelinolysis. Annals of Neurology, 11, 128-135.
40. Chua, G.C., Sitoh, Y.Y., Lim, C.C., Chua, H.C. & Ng, P.Y. (2002) MRI findings in osmotic myelinolysis. Clinical Radiology, 57, 800-806.
41. Ayus, J.C., Wheeler, J.M. & Arieff, A.I. (1992) Postoperative hyponatraemic encephalopathy in menstruant women. Annals of International Medicine, 117, 891-897.
42. Fraser, C.L., Kucharczyk, J., Arieff, A.I., Rollin, C., Sarnacki, P. & Norman, D. (1989a) Sex differences result in increased morbidity form hyponatraemia in female rats. American Journal of Physiology, 256, R880-R885.
43. +-ATPase pump function in rat brain synaptosomes is different in males and females. American Journal of Physiology, 256, E284-E289.
44. Skowsky, V.R., Swan, L. & Smith, P. (1979) Effects of sex hormones on arginine vasopressin in intact and castrated male and female rats. Endocrinology, 104, 105-108.
45. Forrest, J.N., Cox, M., Hong, C., Morrison, G., Bia, M. & Singer, I. (1978) Superiority of demeclocycline over lithium in the treatment of chromic syndrome of inappropriate secretion of antidiuretic hormone. New England Journal of Medicine, 298, 173-177.
46. Decaux, G., Brimiolle, S., Genette, F. & Mockel, J. (1981) Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. American Journal of Medicine, 283, 1081-1083.
47. Decaux, G. (2001) Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea or furosemide. American Journal of Medicine, 110, 582-584.
48. Soupart, A., Stenuit, A., Perier, O. & Decaux, G. (1991) Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea. Clinical Science, 80, 77-84.
49. Soupart, A., Penninckx, R., Stenuit, A. & Decaux, G. (2000) Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatraemia. Brain Research, 852, 167-172.
50. Ayus, J.C. & Arieff, A.I. (1999) Chronic hyponatraemic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. Journal of the American Medical Association, 281, 2299-2304.
51. Saito, T., Ishikawa, S., Ando, F., Higashiyama, M., Nagasaka, S., Sasaki, S. & Saito, T. (2000) Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-deficient rats. American Journal of Physiology, 279, F502-F508.
52. Gross, P., Reimann, D., Henschkowski, J. & Damian, M. (2001) Treatment of severe hyponatraemia: conventional and novel aspects. Journal of the American Society of Nephrology, 12 (Suppl. 17), S10-S14.
53. Ferguson, J.W., Therapondos, G., Newby, D.E. & Hayes, P.C. (2003) Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. Clinical Science, 105, 1-8.
54. 2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomised trial. Circulation, 107, 2690-2696.
55. Wong, F., Blei, A.T., Blendis, L.M. & Thuluvath, P.J. (2003) A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatraemia: a multicentre, randomised, placebo-controlled trial. Hepatology, 37, 182-101.
56. Lane, N. & Allen, K. (1999) Hyponatraemia after orthopaedic surgery. British Medical Journal, 318, 1363-1364.
57. Nzerue, C.M., Baffoe-Bonnie, H., You, W., Falana, B. & Dai, S. (2003) Predictors of outcome in hospitalized patients with severe hyponatraemia. Journal of the National Medical Association, 95, 335-343.